BCL2L11 and colorectal cancer: A recent study had demonstrated that downregulation of both SMS and MYC synergistically induces apoptin Bim expression in colorectal cancer cells, indicating that combined inhibition of SMS and MYC signaling may be an effective therapy for colorectal cancer [47].